Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: Evidence and aspirations

Seminars in Cancer Biology

Volumn 18, Issue 3, 2008, Pages 218-225

  Barnes, Nicholas M ^a   Gordon, John ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Dopamine; Drug reprofiling; Lymphoma; Novel drug targets; Serotonin

Indexed keywords

1 [2 [4 (4 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N METHYLISOCHROMAN 6 CARBOXAMIDE; 2,3 DIHYDRO 3 ISOPROPYL 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 3ALPHA TROPANYLAMIDE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 5 (4 FLUOROBENZAMIDO) 3 (1 METHYL 4 PIPERIDINYL) 1H INDOLE FUMARATE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANTIPARKINSON AGENT; CATECHOLAMINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GRANISETRON; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; PAROXETINE; PNU 10929; RACLOPRIDE; RS 100235; RS 127445; S 33084; SB 236057; SB 656104; SB 699551; SB 714786; SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; VANOXERINE;

B CELL LYMPHOMA; BURKITT LYMPHOMA; DOPAMINERGIC SYSTEM; EVIDENCE BASED MEDICINE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MEDICAL RESEARCH; MONOAMINERGIC SYSTEM; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PARKINSON DISEASE; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

ANIMALS; BIOGENIC MONOAMINES; DOPAMINE; HUMANS; IMMUNE SYSTEM; LYMPHOMA; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 42649102013     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2007.12.007     Document Type: Review

References (30)

1. Mihelic R., Kaufman J., Lonial S., and Flowers C. Maintenance therapy in lymphoma. Clin Lymphoma Myeloma 7 (2007) 507-513
2. Editorial. Reinvention. Lancet Oncol 2006;7:785.
3. Gordon J., and Barnes N.M. Lymphocytes transport serotonin and dopamine: agony or ecstasy?. Trends Immunol 24 (2003) 438-443
4. Rapport M., Green A.A., and Page I.H. Serum vasoconstrictor (serotonin). IV. Isolation and characterisation. J Biol Chem 176 (1948) 1243-1251
5. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
6. Fozard J.R. The peripheral actions of 5-hydroxytryptamine (1989), Oxford University Press
7. Walther D.J., and Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66 (2003) 1673-1680
8. Ledley F.D., Grenett H.E., Bartos D.P., van Tuinen P., Ledbetter D.H., and Woo S.L. Assignment of human tryptophan hydroxylase locus to chromosome 1: gene duplication and translocation in evolution of aromatic amino acid hydroxylases. Somat Cell Mol Genet 13 (1987) 575-580
9. Grahame-Smith D.G. Tryptophan hydroxylation in brain. Biochem Biophys Res Commun 16 (1964) 586-592
10. Masson J., Sagné C., Hamon M., and El Mestikawy S. Neurotransmitter transporters in the central nervous system. Pharmacol Rev 51 (1999) 439-464
11. Walther D.J., Peter J.U., Winter S., Höltje M., Paulmann N., Grohmann M., et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115 (2003) 851-862
12. Guilluy C., Rolli-Derkinderen M., Tharaux P.L., Melino G., Pacaud P., and Loirand G. Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 282 (2007) 2918-2928
13. Iversen S.D., and Iversen L.L. Dopamine: 50 years in perspective. Trends Neurosci 30 (2007) 188-193
14. Fitzpatrick P.F. Tetrahydropterin-dependent amino acid hydroxylases. Ann Rev Biochem 68 (1999) 355-381
15. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 78 (1998) 189-225
16. Meredith E.J., Chamba A., Holder M.J., Barnes N.M., and Gordon J. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115 (2005) 289-295
17. Gordon J., and Barnes N.M. Serotonin: a real blast for T cells. Blood 109 (2007) 3130-3131
18. León-Ponte M., Ahern G.P., and O'Connell P.J. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 109 (2007) 3139-3146
19. Yin J., Albert R.H., Tretiakova A.P., and Jameson B.A. 5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes. J Neuroimmunol 181 (2006) 68-81
20. Serafeim A., Grafton G., Chamba A., Gregory C.D., Blakely R.D., Bowery N.G., et al. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 99 (2002) 2545-2553
21. Meredith E.J., Holder M.J., Chamba A., Challa A., Drake-Lee A., Bunce C.M., et al. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. FASEB J 19 (2005) 1187-1189
22. Chamba A, Holder MJ, Barnes NM, Gordon J. Characterization of the endogenous human peripheral serotonin transporter reveals surface expression without N-glycosylation in lymphocytes. Biochem J, submitted for publication.
23. Bergquist J., Tarkowski A., Ekman R., and Ewing A. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A 91 (1994) 12912-12916
24. McKenna F., McLaughlin P.J., Lewis B.J., Sibbring G.C., Cummerson J.A., Bowen-Jones D., et al. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 132 (2002) 34-40
25. Cosentino M., Fietta A.M., Ferrari M., Rasini E., Bombelli R., Carcano E., et al. Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 109 (2007) 632-642
26. Ilani T., Strous R.D., and Fuchs S. Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J 18 (2004) 1600-1602
27. Sarkar C., Das S., Chakroborty D., Chowdhury U.R., Basu B., Dasgupta P.S., et al. Cutting edge: stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Krüppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation. J Immunol 177 (2006) 7525-7529
28. Watanabe Y., Nakayama T., Nagakubo D., Hieshima K., Jin Z., Katou F., et al. Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol 176 (2006) 848-856
29. Serafeim A., Holder M.J., Grafton G., Chamba A., Drayson M.T., Luong Q.T., et al. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood 101 (2003) 3212-3219
30. Meredith E.J., Holder M.J., Rosén A., Lee A.D., Dyer M.J., Barnes N.M., et al. Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: implications for non-Hodgkin's lymphoma. Proc Natl Acad Sci U S A 103 (2006) 13485-13490